This pharmaceutical stock sets the record date for a 1,500% dividend payout; Key details for investors

Dividend-paying stocks: Divis Laboratories, a large-cap pharmaceutical company, will soon pay the final dividend for the year ending March 2022. While announcing its Q4FY22 results, Divi’s Laboratories said its board recommended a dividend of Rs 30 for the 2021-22 fiscal year. “We would like to inform that the board of directors of the company, at its meeting held on Monday, recommended a dividend of Rs 30/- (i.e. 1500 percent) per share of par value 2/ – each for fiscal year 2021-22, subject to member approval at the following 32nd Annual General Meeting (AGM),’ the pharmaceutical company advised in an exchange filing.

The dividend will be credited/warrants thereof will be dispatched within 30 (thirty) days from the close of the AGM. The date of the AGM and book closing/record date for dividend payment purposes will be communicated in due course, the company added.

The ex-dividend date of the recommended final dividend of 1,500% is August 11, 2022 and the record date is August 12, 2022.

Divi’s Laboratories has a good history of paying dividends since 2003. It has declared 20 continuous dividends since 2003. Of those 20 dividends, 3 were interim dividends and the other 17, including this one, were final dividends. In the past 12 months, the company has declared a 1000% final dividend in shares amounting to Rs 20 per share.


The company, for the quarter ended 31-03-2022, reported total consolidated revenue of Rs 2,570.83 Crore, up 2.43% from last quarter’s total revenue of Rs 2509.86 Crore and up by 41.90% compared to the same quarter last year Total revenue of Rs 1811.71 billion. The company reported a net profit after tax (PAT) of Rs 894.64 Crore in the last quarter.

Stock price history

On May 26, 2022, the stock reached the 52-week high at Rs 3,365.55 per share, while it reached the 52-week high on October 18, 2021 at Rs 5,425.10 per share. The CMP is trading at Rs 321.90 above 52-week lows. The share’s ROE is 25.24%. The PE ratio is 33.07. The PB ratio is 8.35. TTM EPS is Rs 111.52. Over the past week, the company’s shares have gained 2.14%, while over the past month, 4.52%, respectively. The share has slipped 19.64% over the past year, but over the past 5 years it has returned a multi-bagger return of 405.3%. It is a large cap stock with a market capitalization of Rs 97,890 crore.

Divi’s Laboratories Ltd., incorporated in 1990, is a large capitalization company operating in the pharmaceutical sector. It has been established for over 30 years in Hyderabad, India with two manufacturing units and is among the leading pharmaceutical companies in India. Divi’s is the leading manufacturer of APIs (Active Pharmaceutical Ingredients), Intermediates and Registered Raw Materials delivering high quality products with the highest level of compliance and integrity in over 100 countries. It is present on the market in 95 countries with 14,000 employees and is one of the world’s leading pharmaceutical companies.

The views and investment advice of the experts in this report are their own and not those of the website or its management. Users are advised to check with certified experts before making any investment decision.

Read all the latest news, breaking news, watch the best videos and live TV here.

About Warren Dockery

Check Also

Endurance Technologies (NSE:ENDURANCE) next dividend will be higher than last year

Endurance Technologies Limited (NSE: ENDURANCE) announced that it will increase its dividend from last year’s …